🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice

Biomolecules(2023)10.3390/biom13091276Source: DataRank Database

Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice is a research paper published in Biomolecules (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.28)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Ryan Seerattan,Maab Sultan,Trisha Seal,Samaya Danthurthy,Baskaran Chinnappan ORCID

Live enrichment

PubMed:37759675 PMC:PMC10526148 OpenAlex:https://openalex.org/W4386074285

NIH

Grant: R15CA249788

NIH

Grant: SC2GM130470

FWCI

0.28

Citation Percentile

0.5%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-273X/13/9/1276/pdf?version=1692770721

publisherhttps://www.mdpi.com/2218-273X/13/9/1276/pdf?version=1692770721

publisherhttps://www.mdpi.com/2218-273X/13/9/1276/pdf

journalhttps://doi.org/10.3390/biom13091276

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37759675

Fields of Study

RNA Research and SplicingImmunotherapy and Immune ResponsesRNA Interference and Gene Delivery

MeSH Terms

VemurafenibAnimalsHumansMelanomaMice, NudeXenograft Model Antitumor AssaysCell Line, TumorCell ProliferationMiceHeterografts

Keywords

VemurafenibMelanomaMedicineIn vivoCancer researchImmunotherapyMetastatic melanomaImmunologyImmune systemBiologydrug discoveryBrafOrgan HistopathologyCell Line XenograftSpliceosomal Inhibition

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure